潤都股份(002923.SZ):鹽酸伊託必利片獲批上市
格隆匯2月17日丨潤都股份(002923.SZ)公佈,公司近日收到國家藥品監督管理局簽發的《藥品註冊批件》,藥品名稱為鹽酸伊託必利片。
鹽酸伊託必利片適用於因胃腸動力減慢(如功能性消化不良、慢性胃炎等所致)引起的消化不良症狀,包括上腹部飽脹感、上腹痛、食慾不振、噁心和嘔吐等。
公司於2020年7月31日向國家藥品監督管理局藥品審評中心遞交了鹽酸伊託必利片藥品註冊申請,並獲得受理。公司鹽酸伊託必利片以化學藥品註冊分類4類獲批上市,標誌着此產品視同通過仿製藥一致性評價,將對公司的市場拓展帶來積極影響。
公司高度重視藥品研發,並嚴格控制藥品研發、製造及銷售環節的質量及安全。此次獲得鹽酸伊託必利片的藥品註冊批件,將進一步豐富公司消化系統用藥產品線,提高公司市場競爭力。
同時,該產品質量、療效與原研藥品一致。根據國家相關政策,公司產品鹽酸伊託必利片按化學藥品4類批准生產可視同通過仿製藥一致性評價,這將有利於擴大公司產品的市場銷售,對公司的未來經營業績產生積極影響。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.